Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Other Non Operating Income (2021 - 2025)

Historic Other Non Operating Income for Arcutis Biotherapeutics (ARQT) over the last 5 years, with Q3 2025 value amounting to $2.0 million.

  • Arcutis Biotherapeutics' Other Non Operating Income fell 5133.91% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.6 million, marking a year-over-year decrease of 4060.27%. This contributed to the annual value of $16.2 million for FY2024, which is 3722.21% up from last year.
  • As of Q3 2025, Arcutis Biotherapeutics' Other Non Operating Income stood at $2.0 million, which was down 5133.91% from $2.1 million recorded in Q2 2025.
  • Arcutis Biotherapeutics' 5-year Other Non Operating Income high stood at $5.2 million for Q2 2024, and its period low was -$40000.0 during Q4 2021.
  • For the 5-year period, Arcutis Biotherapeutics' Other Non Operating Income averaged around $2.1 million, with its median value being $2.7 million (2023).
  • Per our database at Business Quant, Arcutis Biotherapeutics' Other Non Operating Income soared by 840000.0% in 2022 and then tumbled by 5991.59% in 2025.
  • Quarter analysis of 5 years shows Arcutis Biotherapeutics' Other Non Operating Income stood at -$40000.0 in 2021, then soared by 8400.0% to $3.3 million in 2022, then fell by 19.52% to $2.7 million in 2023, then rose by 1.72% to $2.7 million in 2024, then decreased by 25.13% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $2.1 million for Q2 2025, and $2.7 million during Q1 2025.